IRIS
TRIGGIANESE, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.814
AS - Asia 3.497
EU - Europa 2.330
SA - Sud America 422
OC - Oceania 87
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.697
SG - Singapore 1.597
CN - Cina 743
IT - Italia 427
RU - Federazione Russa 411
BR - Brasile 349
HK - Hong Kong 348
VN - Vietnam 242
DE - Germania 237
IE - Irlanda 218
FR - Francia 211
FI - Finlandia 180
GB - Regno Unito 168
UA - Ucraina 138
BD - Bangladesh 116
JP - Giappone 107
CA - Canada 69
IN - India 63
SE - Svezia 58
NL - Olanda 54
PL - Polonia 51
KR - Corea 46
AU - Australia 44
NZ - Nuova Zelanda 43
ID - Indonesia 38
DK - Danimarca 37
TW - Taiwan 35
ES - Italia 33
BE - Belgio 32
TR - Turchia 30
MX - Messico 29
ZA - Sudafrica 28
EG - Egitto 26
AR - Argentina 25
AT - Austria 22
SA - Arabia Saudita 17
IR - Iran 15
EC - Ecuador 12
MA - Marocco 12
UZ - Uzbekistan 12
IQ - Iraq 11
LV - Lettonia 11
MY - Malesia 10
PH - Filippine 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
LT - Lituania 7
NP - Nepal 6
PE - Perù 6
RO - Romania 6
VE - Venezuela 6
CL - Cile 5
ET - Etiopia 5
PY - Paraguay 5
SI - Slovenia 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HU - Ungheria 4
JM - Giamaica 4
NG - Nigeria 4
BO - Bolivia 3
CH - Svizzera 3
IL - Israele 3
KZ - Kazakistan 3
TN - Tunisia 3
UY - Uruguay 3
YE - Yemen 3
AL - Albania 2
BH - Bahrain 2
BS - Bahamas 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
EU - Europa 1
GT - Guatemala 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MU - Mauritius 1
MV - Maldive 1
Totale 23.232
Salva come PNG Salva come JPEG
Città #
Wilmington 4.094
Houston 3.656
Woodbridge 3.365
Singapore 873
Fairfield 551
Ann Arbor 473
Ashburn 464
Chandler 382
Hong Kong 340
San Jose 299
Seattle 244
Beijing 241
Dallas 235
New York 182
Cambridge 179
Dublin 173
Council Bluffs 150
Medford 136
Santa Clara 135
The Dalles 134
Rome 132
Helsinki 131
Los Angeles 107
Ho Chi Minh City 99
Jacksonville 95
Tokyo 79
Moscow 64
Lawrence 63
Lauterbourg 60
Hanoi 53
São Paulo 50
Buffalo 48
Zhengzhou 48
Dearborn 46
London 44
Redwood City 44
Tauranga 42
Chicago 35
Copenhagen 33
Orem 33
Munich 32
Nanjing 30
Kraków 29
Toronto 29
Amsterdam 28
Brussels 28
Jakarta 27
Nuremberg 27
Chengdu 24
San Diego 24
Shenzhen 24
Johannesburg 23
Shanghai 23
Boardman 22
Seoul 22
Stockholm 22
Taipei 22
Redondo Beach 21
Melbourne 20
Menlo Park 20
Warsaw 20
Milan 19
Phoenix 19
Suzhou 19
Frankfurt am Main 18
Montreal 18
North Bergen 18
Chennai 16
Guangzhou 16
Brooklyn 15
Denver 15
Norwalk 15
Atlanta 13
Jeddah 13
Palo Alto 13
Bassano del Grappa 12
Columbus 12
Scottsdale 12
Tanta 12
Lappeenranta 11
Las Vegas 11
Manchester 11
Boston 10
Brasília 10
Center 10
Charlotte 10
Chongqing 10
Istanbul 10
Kunming 10
Monte Porzio Catone 10
Mumbai 10
San Francisco 10
Ankara 9
Cairo 9
Haiphong 9
Hefei 9
Minoh 9
Rio de Janeiro 9
Bodegraven 8
Cincinnati 8
Totale 18.607
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 856
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 562
Complement, infection, and autoimmunity 545
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 523
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 514
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 510
Autoantibodies in inflammatory arthritis 509
Vasculitides and the Complement System: a Comprehensive Review 503
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 475
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 474
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 472
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 470
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 468
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 463
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 456
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 455
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 453
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 450
HELLP syndrome: A complication or a new autoimmune syndrome? 438
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 431
Auto-reactions, autoimmunity and psoriatic arthritis 431
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 427
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 416
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 412
The interplay between inflammation and metabolism in rheumatoid arthritis 412
Insights on the role of physical activity in patients with rheumatoid arthritis 411
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 398
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 394
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature 370
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 358
Hereditary angioedema and autoimmunity 343
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 342
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 342
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 340
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 316
Interaction between microbiome and host genetics in psoriatic arthritis 300
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 297
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 284
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 272
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 254
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 247
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 246
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 232
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 229
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 222
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 222
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 196
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 192
Severe lupus nephritis: an unexpected association with Fabry disease 192
Vitamin D deficiency in an Italian cohort of infertile women 187
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 177
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review 168
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 168
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 167
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 166
COVID-19: disCOVering the role of complement system 164
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 155
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 152
Tackling the autoimmune side in Spondyloarthritis: a systematic review 143
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 131
The steroid-sparing effect of JAK inhibitors across multiple patient populations 120
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 112
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 107
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 105
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 102
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 102
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 99
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 93
Innate lymphoid cells: a potential innate functional equivalent of adaptive cells in infertility and inflammatory arthropathies 92
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 88
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections 83
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 82
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 81
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 78
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 76
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry (Internal and Emergency Medicine, (2023), 18, 8, (2231-2243), 10.1007/s11739-023-03408-3) 74
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 74
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 73
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 72
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 72
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 72
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 70
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 69
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 69
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 67
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 66
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 65
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 61
Psoriatic Arthritis in Males and Females: Differences and Similarities 59
Subclinical signs of retinal involvement in hereditary angioedema 59
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 56
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 55
Kidney–Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction 44
Unexpected genomic architecture in a sporadic case of C1-INH Hereditary Angioedema: the hidden heritability 42
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 42
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 41
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 41
Kidney–Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction 14
Totale 23.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022717 44 64 61 39 37 43 36 39 37 61 83 173
2022/2023955 88 78 49 126 86 204 80 69 95 18 36 26
2023/2024453 38 16 20 13 70 103 14 48 22 25 23 61
2024/20252.445 74 478 311 134 37 233 104 120 198 193 329 234
2025/20265.025 335 239 622 505 467 200 680 494 476 455 308 244
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 23.679